المؤلفون: Bolivar AM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Duzagac F; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Deng N; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reyes-Uribe L; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chang K; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu W; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bowen CM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taggart MW; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Thirumurthi S; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lynch PM; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., You YN; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodriguez-Pascual J; Department of Medical Oncology, Grupo Vithas, Madrid, Spain., Lipkin SM; Division of Gastroenterology and Hepatology, Weill Cornell University, New York, New York., Kopetz S; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Scheet P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lizee GA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Reuben A; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sinha KM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: EVilar@mdanderson.org.

المصدر: Gastroenterology [Gastroenterology] 2024 May; Vol. 166 (5), pp. 787-801.e11. Date of Electronic Publication: 2024 Jan 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis*/immunology , Antigens, Neoplasm*/immunology , Antigens, Neoplasm*/genetics , Frameshift Mutation* , Exome Sequencing*, Humans ; Female ; Mutation ; Male ; Middle Aged ; DNA Mismatch Repair/genetics ; Microsatellite Repeats ; Microsatellite Instability ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/immunology ; Colorectal Neoplasms/prevention & control ; Adult ; Cancer Vaccines/immunology ; Cancer Vaccines/therapeutic use

المؤلفون: Chaudhri A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Bu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Wang Y; Department of Clinical Science, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States., Gomez M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Torchia JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Hua P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Hung SH; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States., Davies MA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lizee GA; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., von Andrian U; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Department of Immunology & HMS Center for Immune Imaging, Harvard Medical School, Boston, MA, United States.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States., Hwu P; Department of Clinical Science, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Sep 13; Vol. 14, pp. 1237715. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/pharmacology , Antibodies, Monoclonal*/therapeutic use , Tumor Escape*, Mice ; Animals ; Chemokine CX3CL1/metabolism

المؤلفون: Chen CH; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Neurology, Houston Methodist Neurological Institute, Houston, Texas 77030, USA., Chin RL; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Hartley GP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Lea ST; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Engel BJ; Departement of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Hsieh CE; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Prasad R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Roszik J; Departement of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas 77030, USA., Shingu T; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Lizee GA; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Departement of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas 77030, USA., Heimberger AB; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Millward SW; Departement of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Hu J; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Curran MA; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

المصدر: Neuro-oncology [Neuro Oncol] 2023 Aug 03; Vol. 25 (8), pp. 1415-1427.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/pathology, Humans ; Animals ; Mice ; Mice, Inbred C57BL ; Immunotherapy/methods ; T-Lymphocytes/metabolism ; Tumor Microenvironment

المؤلفون: Lyons YA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pradeep S; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu SY; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haemmerle M; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hansen JM; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wagner MJ; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Villar-Prados A; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagaraja AS; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dood RL; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Previs RA; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu W; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhao Y; Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mak DH; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao Z; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Melendez BD; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lizee GA; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mercado-Uribe I; Department of Pathology, Division of Pathology and Laboratory Medicine, Section of Gynecologic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baggerly KA; Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Pathology, Division of Pathology and Laboratory Medicine, Section of Gynecologic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Overwijk WW; Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Coleman RL; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sood AK; Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Oncotarget [Oncotarget] 2017 Aug 24; Vol. 8 (57), pp. 96496-96505. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

المؤلفون: Yee C; From The University of Texas MD Anderson Cancer Center, Houston, TX., Lizee GA

المصدر: Cancer journal (Sudbury, Mass.) [Cancer J] 2017 Mar/Apr; Vol. 23 (2), pp. 144-148.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100931981 Publication Model: Print Cited Medium: Internet ISSN: 1540-336X (Electronic) Linking ISSN: 15289117 NLM ISO Abbreviation: Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*immunology , Immunotherapy, Adoptive/*methods , Neoplasms/*immunology , Neoplasms/*therapy , Precision Medicine/*methods, Humans

المؤلفون: Yoshihama S; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843; Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan;, Roszik J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054;, Downs I; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843;, Meissner TB; Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115;, Vijayan S; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843;, Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;, Sidiq T; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843;, Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115;, Lizee GA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054., Kobayashi KS; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843; kobayashi@medicine.tamhsc.edu.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2016 May 24; Vol. 113 (21), pp. 5999-6004. Date of Electronic Publication: 2016 May 09.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Antigen Presentation* , Tumor Escape*, Biomarkers, Tumor/*immunology , Gene Expression Regulation, Neoplastic/*immunology , Histocompatibility Antigens Class I/*immunology , Intracellular Signaling Peptides and Proteins/*immunology , Neoplasm Proteins/*immunology , Neoplasms/*immunology , Trans-Activators/*immunology , Transcriptional Activation/*immunology, ATP Binding Cassette Transporter, Subfamily B, Member 2/genetics ; ATP Binding Cassette Transporter, Subfamily B, Member 2/immunology ; Biomarkers, Tumor/genetics ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Cysteine Endopeptidases/genetics ; Cysteine Endopeptidases/immunology ; Female ; Histocompatibility Antigens Class I/genetics ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Male ; Neoplasm Proteins/genetics ; Neoplasms/genetics ; Neoplasms/mortality ; Neoplasms/pathology ; Proteasome Endopeptidase Complex/genetics ; Proteasome Endopeptidase Complex/immunology ; Trans-Activators/genetics ; beta 2-Microglobulin/genetics ; beta 2-Microglobulin/immunology

المؤلفون: Zhu K; Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States., Qin H, Cha SC, Neelapu SS, Overwijk W, Lizee GA, Abbruzzese JL, Hwu P, Radvanyi L, Kwak LW, Chang DZ

المصدر: Vaccine [Vaccine] 2007 Nov 14; Vol. 25 (46), pp. 7955-61. Date of Electronic Publication: 2007 Sep 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0264-410X (Print) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*immunology , Lymphoma/*prevention & control , Microtubule-Associated Proteins/*immunology , Neoplasm Proteins/*immunology , Pancreatic Neoplasms/*prevention & control , Vaccines, DNA/*immunology, Animals ; Cancer Vaccines/genetics ; Cell Line, Tumor ; Female ; Humans ; Inhibitor of Apoptosis Proteins ; Lymphocytes/immunology ; Lymphoma/genetics ; Lymphoma/immunology ; Mice ; Mice, Inbred BALB C ; Microtubule-Associated Proteins/genetics ; Neoplasm Proteins/genetics ; Neoplasms, Experimental/genetics ; Neoplasms, Experimental/immunology ; Neoplasms, Experimental/prevention & control ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/immunology ; Repressor Proteins ; Survivin ; Vaccines, DNA/genetics